Discuss Abbott Laboratories
Abbott Laboratories
WKN: 850103 / Symbol: ABT / Name: Abbott / Aktie / Pharmazeutika / Large Cap /
77,82 €
1,25 %
Abbott Laboratories (ABT) had its price target lowered by Benchmark Co. from $145.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its "buy" rating reaffirmed by BTIG Research. They now have a $131.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by Stifel Nicolaus from $145.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by Bank of America Corporation from $150.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by Royal Bank Of Canada from $135.00 to $130.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by Sanford C. Bernstein from $125.00 to $110.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by Evercore Inc from $134.00 to $120.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by Raymond James Financial, Inc. from $130.00 to $115.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by Wells Fargo & Company from $122.00 to $109.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by JPMorgan Chase & Co. from $123.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by Piper Sandler from $135.00 to $115.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by Jefferies Financial Group Inc. from $145.00 to $135.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by Citigroup Inc. from $136.00 to $108.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by TD Cowen from $137.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by Oppenheimer Holdings, Inc. from $132.00 to $115.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by Barclays PLC from $144.00 to $143.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by UBS Group AG from $158.00 to $135.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by Argus from $140.00 to $125.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its "buy" rating reaffirmed by BTIG Research. They now have a $131.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (ABT) had its price target lowered by The Goldman Sachs Group, Inc. from $121.00 to $113.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Neueste Beiträge
Wolfe_Research in Target Corp. diskutieren